News

With the closing of the acquisitions of Neovasc Medical and B-Balloon, both pre-commercial stage medical device companies based in Israel, Neovasc has significantly expanded its new product pipeline.

The last person in each study has completed the primary efficacy follow-up visit, and collation of this data has begun. The company anticipates that top-line efficacy and safety

Under this co-promotion agreement, Paladin will maintain regulatory and supply responsibilities for Seasonale and will continue to support Seasonale using its national specialty sales force. P&G Pharmaceuticals Canada

The receipt of the State Food and Drug Administration (SFDA) certificates will allow Chindex to begin the sales process and launch official marketing programs for these products, creating

The trial is an open-label, Simon two-stage design to evaluate the safety and efficacy of a combination of bavituximab and docetaxel in metastatic breast cancer patients. Approximately 14

According to the company, the integrated electrophysiology (EP) solution offers a software interface between the Hansen Medical Sensei robotic catheter system and the EnSite system advanced mapping software

Boston Scientific’s Promus stent is a private-labeled Xience V everolimus-eluting coronary stent system manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the

The acquisition of the products from these two different companies will provide Glenmark its first access to the growing Polish market, the largest pharmaceutical market in Central and

The company intends to use the net proceeds for working capital and general corporate purposes. The first closing occurred on June 30, 2008, and subsequent closings are subject